Cogent Biosciences, Inc. (COGT)


Stock Price Forecast

April 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Cogent Biosciences, Inc. chart...

About the Company

We do not have any company description for Cogent Biosciences, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

146

Exchange

Nasdaq

$489M

Total Revenue

146

Employees

$569M

Market Capitalization

-2.77

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $COGT News

Cogent Biosciences Presents Data Highlighting Potential Best-in-Class Potency and Selectivity of Novel, EGFR Sparing, CNS-Penetrant ErbB2 Inhibitor

11d ago, source:

WALTHAM, Mass. and BOULDER, Colo., April 09, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a ...

Buy Rating Affirmed for Mirum Pharmaceuticals Amid Positive Clinical Trial Outlook

4d ago, source:

Citi analyst David Lebovitz has maintained their bullish stance on MIRM stock, giving a Buy rating on April 8. David Lebovitz has given his ...

Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session

4d ago, source:

Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session U.S. stock ...

Economic developers brand Lansing as key leg of Michigan’s ‘Research Triangle’

3d ago, source: crainsgrandrapids

A consortium of groups has set out to brand Lansing as a bioscience destination in a move to better position the region ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...